PCR detection of Burkholderia cepacia complex as one of key factors to handle a long- term outbreak  Klara Dedeckova, Libor Fila, Veronika Skalicka, Jana.

Slides:



Advertisements
Similar presentations
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Advertisements

Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a Cystic Fibrosis patient  Joshua R. Stokell, Raad Z. Gharaibeh, Todd R.
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in childrenwith cystic fibrosis  Cori Daines, Donald VanDeVanter,
Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex  Yury Herasimenka, Paola Cescutti, Giuseppe Impallomeni,
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
A 10-year large-scale cystic fibrosis carrier screening in the Italian population  Luigi Picci, Marilena Cameran, Oriana Marangon, Diana Marzenta, Stefano.
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D
Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients  Klara.
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis
Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations  Melanie Chin, Maya De Zoysa, Robert.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Pulmonary nocardiosis in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography  J. Elias, C. Schoen, G. Heinze,
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson 
Stenotrophomonas maltophilia in cystic fibrosis: Improved detection by the use of selective agar and evaluation of antimicrobial resistance  P. Goncalves-Vidigal,
Nasal polyposis in lung transplant recipients with cystic fibrosis
Elliott C. Dasenbrook, Gregory S. Sawicki  Journal of Cystic Fibrosis 
Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint  M.W. Konstan, J.S. Wagener, A. Yegin, S.J.
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatment  Matthias Kappler,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
A. Sapet, A. C. Normand, M. Oudyi, N. Stremler- Le Bel, R. Piarroux, J
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in childrenwith cystic fibrosis  Cori Daines, Donald VanDeVanter,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case– control study  Maarten Verregghen, Harry G. Heijerman, Monique.
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005  Donald R. VanDevanter, Eric P. Elkin,
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Segregation—the perspectives of young patients and their parents
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

PCR detection of Burkholderia cepacia complex as one of key factors to handle a long- term outbreak  Klara Dedeckova, Libor Fila, Veronika Skalicka, Jana Bartosova, Tereza Kucerova, Vera Vavrova, Dana Zemkova, Lucie Kalferstova, Oto Melter, Ondrej Cinek, Pavel Drevinek  Journal of Cystic Fibrosis  Volume 11, Issue 5, Pages 440-445 (September 2012) DOI: 10.1016/j.jcf.2012.04.005 Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Overview of longitudinal microbiological results in subjects with Bcc infection diagnosed by PCR. (A) Cases with subsequent Bcc positive cultures; (B) Cases with negative cultures. All investigations performed within a three-year period that followed the first PCR finding are depicted on a time scale. Sample positivity is indicated by filling appropriate parts of the circle as follows: bottom=PCR examination; top=culture examination. Journal of Cystic Fibrosis 2012 11, 440-445DOI: (10.1016/j.jcf.2012.04.005) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Summary of Bcc infections in the Prague CF Centre over 1994–2010. The left bar indicates the number of new cases of the Bcc infection; the right bar represents all cases per calendar year. Patients with ST32 infection are highlighted in black; infections with all other Bcc strains are in gray. Please note that no incidence data is provided for initial two years of the study (1994–1995) during which screening of the CF population on Bcc infection has been commenced. Journal of Cystic Fibrosis 2012 11, 440-445DOI: (10.1016/j.jcf.2012.04.005) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions